News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
309,927 Results
Type
Article (15068)
Company Profile (106)
Press Release (294745)
Multimedia
Podcasts (65)
Webinars (13)
Section
Business (97929)
Career Advice (475)
Deals (17532)
Drug Delivery (73)
Drug Development (40161)
Employer Resources (50)
FDA (7192)
Job Trends (6617)
News (167164)
Policy (15605)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (518)
Accelerated approval (15)
Adcomms (8)
Allergies (77)
Alliances (26835)
ALS (64)
Alzheimer's disease (571)
Antibody-drug conjugate (ADC) (135)
Approvals (7427)
Artificial intelligence (216)
Autoimmune disease (51)
Automation (13)
Bankruptcy (152)
Best Places to Work (4686)
BIOSECURE Act (9)
Biosimilars (134)
Biotechnology (42)
Bladder cancer (54)
Brain cancer (34)
Breast cancer (210)
Cancer (1612)
Cardiovascular disease (164)
Career advice (427)
Career pathing (13)
CAR-T (62)
CDC (6)
Cell therapy (198)
Cervical cancer (11)
Clinical research (35137)
Collaboration (847)
Compensation (342)
Complete response letters (36)
COVID-19 (893)
CRISPR (47)
C-suite (471)
Cystic fibrosis (63)
Data (2182)
Denatured (18)
Depression (55)
Diabetes (145)
Diagnostics (1882)
Digital health (12)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (131)
Drug pricing (115)
Drug shortages (12)
Duchenne muscular dystrophy (104)
Earnings (37396)
Editorial (22)
Employer branding (4)
Employer resources (46)
Events (43353)
Executive appointments (562)
FDA (8494)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (517)
Gene editing (79)
Generative AI (19)
Gene therapy (196)
GLP-1 (465)
Government (1539)
Grass and pollen (5)
Guidances (176)
Healthcare (4273)
HIV (12)
Huntington's disease (11)
IgA nephropathy (46)
Immunology and inflammation (74)
Immuno-oncology (17)
Indications (57)
Infectious disease (970)
Inflammatory bowel disease (82)
Inflation Reduction Act (8)
Influenza (33)
Intellectual property (126)
Interviews (60)
IPO (6815)
IRA (33)
Job creations (2139)
Job search strategy (383)
JPM (30)
Kidney cancer (9)
Labor market (28)
Layoffs (208)
Leadership (8)
Legal (3805)
Liver cancer (35)
Longevity (8)
Lung cancer (226)
Lymphoma (147)
Machine learning (13)
Management (17)
Manufacturing (464)
MASH (77)
Medical device (2333)
Medtech (2346)
Mergers & acquisitions (11220)
Metabolic disorders (484)
Multiple sclerosis (59)
NASH (14)
Neurodegenerative disease (98)
Neuropsychiatric disorders (41)
Neuroscience (1050)
Neurotech (1)
NextGen: Class of 2026 (1723)
Non-profit (667)
Now hiring (18)
Obesity (248)
Opinion (142)
Ovarian cancer (40)
Pain (114)
Pancreatic cancer (65)
Parkinson's disease (99)
Partnered (11)
Patents (241)
Patient recruitment (155)
Peanut (13)
People (31808)
Pharmaceutical (63)
Pharmacy benefit managers (19)
Phase 1 (9292)
Phase 2 (14952)
Phase 3 (13167)
Pipeline (2256)
Policy (137)
Postmarket research (1449)
Preclinical (3718)
Press Release (27)
Prostate cancer (101)
Psychedelics (16)
Radiopharmaceuticals (149)
Rare diseases (381)
Real estate (2953)
Recruiting (19)
Regulatory (12189)
Reports (17)
Research institute (649)
Resumes & cover letters (56)
Rett syndrome (5)
RNA editing (7)
RSV (22)
Schizophrenia (73)
Series A (92)
Series B (70)
Service/supplier (3)
Sickle cell disease (52)
Special edition (10)
Spinal muscular atrophy (83)
Sponsored (9)
Startups (1874)
State (2)
Stomach cancer (6)
Supply chain (51)
Tariffs (68)
The Weekly (45)
Vaccines (270)
Venture capital (39)
Weight loss (142)
Women's health (30)
Worklife (4)
Date
Today (4)
Last 7 days (228)
Last 30 days (768)
Last 365 days (11796)
2026 (1340)
2025 (12115)
2024 (14177)
2023 (16236)
2022 (22888)
2021 (23451)
2020 (22022)
2019 (16793)
2018 (13113)
2017 (15489)
2016 (14675)
2015 (17286)
2014 (13960)
2013 (11979)
2012 (12879)
2011 (13382)
2010 (12146)
Location
Africa (349)
Alabama (21)
Alaska (1)
Arizona (83)
Arkansas (3)
Asia (32011)
Australia (4099)
California (3595)
Canada (1648)
China (723)
Colorado (148)
Connecticut (146)
Delaware (129)
Europe (47459)
Florida (633)
Georgia (70)
Hawaii (1)
Idaho (10)
Illinois (369)
India (53)
Indiana (242)
Iowa (3)
Japan (359)
Kansas (81)
Kentucky (20)
Louisiana (5)
Maine (5)
Maryland (503)
Massachusetts (2940)
Michigan (52)
Minnesota (193)
Mississippi (1)
Missouri (43)
Montana (8)
Nebraska (7)
Nevada (23)
New Hampshire (9)
New Jersey (1591)
New Mexico (7)
New York (1055)
North Carolina (667)
North Dakota (4)
Northern California (1624)
Ohio (87)
Oklahoma (6)
Oregon (19)
Pennsylvania (793)
Puerto Rico (13)
Rhode Island (18)
South America (560)
South Carolina (10)
Southern California (1585)
Tennessee (55)
Texas (497)
United States (14239)
Utah (80)
Virginia (161)
Washington D.C. (44)
Washington State (261)
West Virginia (1)
Wisconsin (40)
Wyoming (1)
309,927 Results for "beacon pharmaceuticals ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Beacon Therapeutics Announces Closing of Oversubscribed Series C Financing for Over $75 Million
January 8, 2026
·
5 min read
Press Releases
Beacon Therapeutics to Present at the 44th Annual JP Morgan Healthcare Conference
December 19, 2025
·
1 min read
Press Releases
Beacon Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference
November 13, 2025
·
1 min read
Press Releases
Beacon Biosignals Announces Partnership with Harmony Biosciences to Advance Objective Clinical Endpoints in Hypersomnia Conditions Through Quantitative EEG
December 16, 2025
·
3 min read
Press Releases
Beacon Therapeutics Treats First Patient in LANDSCAPE Trial of laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP)
December 17, 2025
·
4 min read
Press Releases
Beacon Biosignals Raises $86M to Accelerate AI-Driven Insights into Brain Health
November 13, 2025
·
5 min read
Press Releases
Faron Pharmaceuticals Ltd: Appointment of CFO
December 1, 2025
·
3 min read
Press Releases
Beacon Biosignals Announces Multi-Year Expansion of Strategic Collaboration with Takeda to Advance Narcolepsy Diagnosis and Neurobiomarker Discovery
November 19, 2025
·
2 min read
Press Releases
Faron Pharmaceuticals Ltd: Holding(s) in Company
December 5, 2025
·
3 min read
Immunology and inflammation
Priovant Plots Path to Phase 3 as Brepocitinib Clears Mid-Stage Skin Disease Study
According to Priovant, the Phase 2 BEACON study is the first industry-sponsored placebo-controlled trial in cutaneous sarcoidosis to deliver positive data.
February 6, 2026
·
2 min read
·
Tristan Manalac
1 of 30,993
Next
